India: Novartis fights on in Gleevec battle
Novartis has now appealed to the Supreme Court in a bid to overturn the rejection of its controversial patent for Gleevec. Archana Shanker of Anand and Anand discusses the issues raised by the case
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: